Estimation of Quercetin Treatment Effects in Polycystic Ovarian Syndrome (PCOS) Induced Rats
DOI:
https://doi.org/10.31351/vol34iss3pp111-118Keywords:
Biochemical assay, lipid profile, PCOS, Quercetin, Testosterone propionate.Abstract
Polycystic ovary syndrome (PCOS), also known as a common polygenic endocrine condition, affects the ovaries and results in infertility and abortion. Dyslipidemia, Diabetes, hypertension, endometrial cancer, and other illnesses may all be made more likely by PCOS. Various drugs are used to treat PCOS, but they have several drawbacks and cannot effectively cure the condition. Therefore, and due to its strong antioxidant activity, anti-obesity, anti-inflammation, and other actions, the flavonoid quercetin has been proven to have health-promoting properties. The purpose of the study was to assess quercetin's impact activity in the treatment of PCOS - induced rats. A PCOS rat model was developed using testosterone. Female albino Wistar rats (170±10 g) were subcutaneously injected with either testosterone propionate (TP) 10 mg/kg/day body weight or propylene glycol (PG) as vehicle 0.5ml daily, for 28 days (induction stage). The PCOS-induced rats were divided into two groups, one was treated orally with the vehicle (PG) and the other was treated orally with quercetin 25mg/kg/day over a period of 35 days (treatment stage). So, the biochemical assays proved the efficacy of quercetin on lipid profile and glucose uptake, in rat treatment with quercetin significantly decreased (P < 0.05) in body weight and fasting blood glucose, fasting insulin, cholesterol and triglyceride levels unlike PCOS-induced rats also, a significant increase in HDL level was achieved in quercetin - treated group compared to PCOS group. Thus, we conclude that quercetin is an effective remedy in modulating metabolic features and treating PCOS.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Kim EJ, Jang M, Choi JH, et al. An improved dehydroepiandrosterone-induced rat model of polycystic ovary syndrome (PCOS): post-pubertal improve PCOS's features. Frontiers in endocrinology. 2018 4; 9:735.
Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine reviews. 1997; 18(6):774-800.
Witchel SF, Roumimper H, Oberfield S, et al. Polycystic ovary syndrome in adolescents. Endocrinology and Metabolism Clinics. 2016; 45(2):329-44.
Rotterdam ES. consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1):19-25.
Xia H, Zhao Y. miR-155 is high-expressed in polycystic ovarian syndrome and promotes cell proliferation and migration through targeting PDCD4 in KGN cells. Artificial cells, nanomedicine, and biotechnology. 2020; 48(1):197-205.
Yuan C, Liu X, Mao Y et al. Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study. Journal of biomedical research. 2016 May;30(3):197.
Russo M, Spagnuolo C, Tedesco I et al. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochemical pharmacology. 2012 Jan 1; 83(1):6-15.
Baldauff NH, Witchel SF. Polycystic ovary syndrome in adolescent girls. Current Opinion in Endocrinology & Diabetes and Obesity. 2017 Feb 1;24(1):56-66.
Akerele O, Heywood V, Synge H et al. Conservation of medicinal plants. Cambridge University Press; 1991 Jul 26.
Chen C, Zhou J, Ji C et al. Quercetin: a potential drug to reverse multidrug resistance. Life sciences. 2010 Sep 11;87(11-12):333-8.
Jahan S, Abid A, Khalid S et al. Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study. Journal of ovarian research. 2018 Dec;11(1):1-0.
Kleemann R, Verschuren L, Morrison M et al. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis. 2011 Sep 1;218(1):44-52.
Kafali H, Iriadam M, Ozardalı I et al. Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Archives of medical research. 2004 Mar 1;35(2):103-8.
Gambineri A, Pelusi C, Vicennati V et al. Obesity and the polycystic ovary syndrome. International journal of obesity. 2002 Jul;26(7):883-96.
Leckey LC, Garige M, Varatharajalu R et al. Quercetin and ethanol attenuate the progression of atherosclerotic plaques with concomitant up regulation of paraoxonase1 (PON1) gene expression and PON1 activity in LDLR−/− mice. Alcoholism: Clinical and Experimental Research. 2010 Sep;34(9):1535-42.
Cao Yang CY, Zhuang MengFei ZM, Yang Ying YY et al. Preliminary study of quercetin affecting the hypothalamic-pituitary-gonadal axis on rat endometriosis model.2014.
Doi SA, Al-Zaid M, Towers PA et al. Irregular cycles and steroid hormones in polycystic ovary syndrome. Human Reproduction. 2005 Sep 1;20(9):2402-8.
Shah KN, Patel SS. Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome. Pharmaceutical biology. 2016 Jun 2;54(6):975-83.
Pourteymour Fard Tabrizi F, Hajizadeh-Sharafabad F, Vaezi M et al. Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review. Journal of Ovarian Research. 2020 Dec; 13(1):1-0.
Hong Y, Yin Y, Tan Y et al. Effect of quercetin on biochemical parameters in letrozole induced polycystic ovary syndrome in rats. Tropical Journal of Pharmaceutical Research, 2018:17(9), 1783.
Wang Z, Zhai D, Zhang D et al. Quercetin decreases insulin resistance in a polycystic ovary syndrome rat model by improving inflammatory microenvironment. Reproductive Sciences. 2017; 24(5):682-90.
Yu J, Zhai D, Hao L et al. Cryptotanshinone reverses reproductive and metabolic disturbances in PCOS model rats via regulating the expression of CYP17 and AR. Evidence-Based Complementary and Alternative Medicine. 2014 Oct;2014.
Henagan TM, Cefalu WT, Ribnicky DM et al. In vivo effects of dietary quercetin and quercetin-rich red onion extract on skeletal muscle, mitochondria, metabolism, and insulin sensitivity. Genes Nutr. 2015;10:451.
Neisy A, Zal F, Seghatoleslam A et al.. Amelioration by quercetin of insulin resistance and uterine GLUT4 and ERα gene expression in rats with polycystic ovary syndrome (PCOS). Reproduction, Fertility and Development. 2019 Jan 21; 31(2):315-23.
Ma C, Xiang Q, Song G et al. Quercetin and polycystic ovary syndrome. Frontiers in Pharmacology. 2022 Dec 16; 13:1006678.
Ahn J, Lee H, Kim S et al. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochemical and biophysical research communications. 2008; 373(4):545-9.
Rodrigues B.A., Muñoz V.R., Kuga G.K. et al. Obesity Increases Mitogen-Activated Protein Kinase Phosphatase-3 Levels in the Hypothalamus of Mice. Front. Cell. Neurosci. 2017;11:313.
Rezvan N, Moini A, Janani L et al. Effects of quercetin on adiponectin-mediated insulin sensitivity in polycystic ovary syndrome: a randomized placebo-controlled double-blind clinical trial. Hormone and Metabolic Research. 2017; 49(02):115-21.
Yarahmadi A, Zal F, Bolouki A et al. Protective effects of quercetin on nicotine induced oxidative stress in ‘HepG2 cells’. Toxicology Mechanisms and Methods. 2017; 27(8):609-14.
Anhê GF, Okamoto MM, Kinote A et al. Quercetin decreases inflammatory response and increases insulin action in skeletal muscle of ob/ob mice and in L6 myotubes. European journal of pharmacology. 2012; 689(1-3):285-93.
Rezvan N, Moini A, Gorgani-Firuzjaee S et al. Oral quercetin supplementation enhances adiponectin receptor transcript expression in polycystic ovary syndrome patients: a randomized placebo-controlled double-blind clinical trial. Cell Journal . 2018; 19(4):627.
Eid HM, Nachar A, Thong F et al. The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes. Pharmacognosy magazine. 2015; 11(41):74.
Jeong SM, Kang MJ, Choi HN et al. Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutrition research and practice. 2012; 6(3):201-7.
Lin R, Liu J, Gan W et al. Protection of vascular endothelial cells from TNF-alpha induced injury by quercetin. Journal of Chinese Medicinal Materials. 2004 Aug 1; 27(8):597-9.
Xu D, Hu MJ, Wang YQ et al. Antioxidant activities of quercetin and its complexes for medicinal application. Molecules. 2019 Mar 21; 24(6):1123.
Duez H, Lamarche B, Valéro R et al. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans. Circulation. 2008 May 6;117(18):2369-76.
Yi H, Peng H, Wu X et al. The therapeutic effects and mechanisms of quercetin on metabolic diseases: pharmacological data and clinical evidence. Oxidative medicine and cellular longevity. 2021 Jun 23;2021.
Browning, J. D., and J. D. Horton. 2004. Molecular mediators of hepatic steatosis and liver injury. The Journal of Clinical Investigation. 2004 FEB114 (2):147–52.
Beekmann K, Rubió L, de Haan LH et al. The effect of quercetin and kaempferol aglycones and glucuronides on peroxisome proliferator-activated receptor-gamma (PPAR-γ). Food & function. 2015;6(4):1098-107.
Tabrizi R, Tamtaji OR, Mirhosseini N et al. The effects of quercetin supplementation on lipid profiles and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020;60(11):1855-1868.
Bentz AB. A Review of quercetin: chemistry, antioxident properties, and bioavailability. Journal of young investigators. 2017 Apr 1.
Larson AJ, Symons JD, Jalili T et al. Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms. Advances in nutrition. 2012 Jan;3(1):39-46.
Hoek-van den Hil EF, Keijer J, Bunschoten A et al. Quercetin induces hepatic lipid omega-oxidation and lowers serum lipid levels in mice. PloS one. 2013 Jan 24;8(1):e51588.
Gnoni A, Di Chiara Stanca B, Giannotti L et al. Quercetin reduces lipid accumulation in a cell model of NAFLD by inhibiting de novo fatty acid synthesis through the acetyl-CoA carboxylase 1/AMPK/PP2A Axis. International Journal of Molecular Sciences. 2022 Jan 18;23(3):1044.
Wang M, Mao Y, Wang B et al. Quercetin improving lipid metabolism by regulating lipid metabolism pathway of ileum mucosa in broilers. Oxidative medicine and cellular longevity. 2020;2020.
Kuipers E.N, Dam A, Held N.M et al. Quercetin Lowers Plasma Triglycerides Accompanied by White Adipose Tissue Browning in Diet-Induced Obese Mice. Int. J. Mol. Sci. 2018;19:1786.
Wang M, Xiao F.L, Mao Y.J et al. Quercetin decreases the triglyceride content through the PPAR signalling pathway in primary hepatocytes of broiler chickens. Biotechnol. Equip. 2019;33:1000–1010.
Muselin F, Cristina RT, Dumitrescu E et al. Quercetin Beneficial Role in the Homeostatic Variation of Certain Trace Elements in Dyslipidemic Mice. Evidence-Based Complementary and Alternative Medicine. 2022 Mar 11;2022.
Gong M, Garige M, Varatharajalu R et al. (). Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation. Biochemical and Biophysical Research Communications. 2009:379(4), 1001–1004.
Tremellen K, Pearce K. Dysbiosis of Gut Microbiota (DOGMA)--a novel theory for the development of Polycystic Ovarian Syndrome. Med Hypotheses. 2012 Jul;79(1):104-12.
Rizk MG, Thackray VG. Intersection of polycystic ovary syndrome and the gut microbiome. Journal of the Endocrine Society. 2021 Feb;5(2):bvaa177.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
